NOVN - Novan Inc Stock Price, Fair Value and News

0.03USD0.00 (0.00%)Market Closed

Market Summary

USD0.030.00

Market Closed

0.00%

NOVN Stock Price

View Fullscreen

NOVN RSI Chart

NOVN Valuation

Market Cap

840.5K

Price/Earnings (Trailing)

-0.03

Price/Sales (Trailing)

0.03

Price/Free Cashflow

-0.02

NOVN Price/Sales (Trailing)

NOVN Profitability

Free Cashflow Yield

-4.7K%

NOVN Fundamentals

NOVN Revenue

NOVN Earnings

Breaking Down NOVN Revenue

Last 30 days

-40%

Last 90 days

-92.9%

Trailing 12 Months

-98.7%

How does NOVN drawdown profile look like?

NOVN Financial Health

NOVN Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	24.9M	0	0	0
2022	4.1M	9.5M	13.9M	23.7M
2021	4.5M	4.0M	3.4M	3.0M
2020	5.0M	5.2M	5.2M	4.9M
2019	6.4M	6.9M	7.6M	4.9M
2018	2.9M	2.8M	2.6M	6.0M
2017	716.3K	1.3M	1.9M	2.5M
2014	0	0	0	112.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Novan Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jun 27, 2023	sanders machelle	sold	-4,715	0.4082	-11,553	-
Jun 07, 2023	gay john m.	acquired	-	-	65,000	chief financial officer
Jun 07, 2023	keegan robert j	acquired	-	-	36,101	-
Jun 07, 2023	bierman james l	acquired	-	-	36,101	-
Jun 07, 2023	skolsky steven d	acquired	-	-	36,101	-
Jun 07, 2023	geer w kent	acquired	-	-	36,101	-
Jun 07, 2023	sanders machelle	acquired	-	-	36,101	-
Jun 07, 2023	gay john m.	sold (taxes)	-	-	-20,669	chief financial officer
Apr 07, 2022	bierman james l	bought	3,448	3.4488	1,000	-
Mar 28, 2022	bierman james l	bought	3,450	3.45	1,000	-

Which funds bought or sold NOVN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Sep 09, 2022	B. Riley Wealth Management, Inc.	added	32.69	-234,816	184	-%
Jan 06, 2022	Carroll Financial Associates, Inc.	unchanged	-	-	-	-%
Nov 15, 2021	Marshall Wace North America L.P.	reduced	-86.06	-2,614,000	332,000	-%

Are Funds Buying or Selling NOVN?

Are funds buying NOVN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NOVN

No. of Funds

Unveiling Novan Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Jun 24, 2021	reedy creek investments llc	4.1%	789,474	SC 13D/A
Jun 21, 2021	ra capital management, l.p.	0%	0	SC 13G
Jan 27, 2021	moglia joseph h	2.2%	3,179,000	SC 13D/A
Jan 06, 2021	reedy creek investments llc	5.4%	7,894,736	SC 13D/A
Jan 05, 2021	sabby management, llc	12.%	0	SC 13G/A
Jun 18, 2020	reedy creek investments llc	9.3%	7,894,736	SC 13D/A
Apr 02, 2020	reedy creek investments llc	11.1%	7,894,736	SC 13D/A
Mar 27, 2020	moglia joseph h	7.2%	4,872,211	SC 13D/A
Mar 13, 2020	reedy creek investments llc	16.8%	7,894,736	SC 13D/A
Mar 13, 2020	moglia joseph h	8.2%	3,872,211	SC 13D

Recent SEC filings of Novan Inc

View All Filings

Date Filed	Form Type	Document
May 01, 2024	POS AM	POS AM
May 01, 2024	EFFECT	EFFECT
May 01, 2024	EFFECT	EFFECT
May 01, 2024	EFFECT	EFFECT
May 01, 2024	EFFECT	EFFECT
May 01, 2024	EFFECT	EFFECT
May 01, 2024	EFFECT	EFFECT
May 01, 2024	EFFECT	EFFECT
May 01, 2024	EFFECT	EFFECT
May 01, 2024	8-K	Current Report

Novan Inc News

Latest updates

Novan Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2	2018Q1
Revenue	-69.8%	3,166,000	10,481,000	5,115,000	6,158,000	1,928,000	655,000	737,000	747,000	819,000	1,069,000	1,317,000	1,321,000	1,213,000	1,379,000	1,316,000	1,101,000	1,100,000	4,036,000	648,000	649,000	658,000
Costs and Expenses	26.9%	16,999,000	13,394,000	14,919,000	14,444,000	15,154,000	8,747,000	7,220,000	7,802,000	9,104,000	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	8,747,000	7,220,000	7,802,000	9,104,000	8,581,000	9,716,000	9,414,000	7,423,000	7,375,000	10,888,000	9,500,000	7,821,000	7,549,000	8,992,000	8,796,000	9,215,000
S&GA Expenses	44.4%	10,040,000	6,952,500	8,562,000	8,594,000	9,994,000	4,257,000	2,969,000	2,431,000	2,686,000	2,424,000	3,108,000	3,232,000	2,507,000	1,817,000	2,290,000	3,311,000	2,994,000	2,712,000	3,295,000	2,620,000	2,880,000
R&D Expenses	29.7%	4,832,000	3,725,000	4,288,000	3,144,000	4,833,000	4,490,000	4,251,000	5,257,000	6,418,000	6,301,000	4,836,000	3,761,000	4,916,000	5,558,000	8,598,000	6,189,000	4,827,000	4,837,000	5,697,000	6,176,000	6,335,000
EBITDA Margin	-Infinity%	-2.13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expenses	259.7%	277,000	77,000	635,000	608,000	132,000	-	-	-	-	-500	-	-	-	1,000	-	1,000	-	262,000	262,000	261,000	262,000
Income Taxes	-	56,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	-Infinity%	-14,063,000	-	-	-	-13,380,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBT Margin	-Infinity%	-2.26	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-367.1%	-14,119,000	-3,023,000	-6,030,000	-8,878,000	-13,380,000	-8,233,000	-6,484,000	-6,023,000	-8,952,000	-6,635,000	-8,405,000	-8,086,000	-6,167,000	-5,948,000	-9,496,000	-8,296,000	-6,637,000	-3,680,000	-8,495,000	-8,289,000	-8,775,000
Net Income Margin	2.7%	-1.29	-1.32	-2.64	-3.90	-8.39	-10.04	-8.33	-7.59	-7.09	-5.95	-5.47	-5.68	-	-	-	-	-	-	-	-	-
Free Cashflow	64.9%	-4,273,000	-12,173,000	-9,839,000	-12,982,000	-162,000	-13,276,000	-6,752,000	-4,264,000	-9,535,000	-9,425,000	-8,136,000	-6,357,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2	2018Q1
Assets	-11.7%	80.00	90.00	83.00	114	112	69.00	74.00	80.00	47.00	47.00	47.00	47.00	37.00	29.00	37.00	48.00	22.00	26.00	30.00	39.00	46.00
Current Assets	-22.9%	33.00	42.00	35.00	62.00	59.00	54.00	62.00	69.00	41.00	44.00	45.00	38.00	23.00	16.00	22.00	32.00	7.00	9.00	13.00	22.00	29.00
Cash Equivalents	1.8%	13.00	12.00	15.00	37.00	35.00	48.00	60.00	66.00	33.00	36.00	43.00	35.00	22.00	14.00	16.00	22.00	6.00	9.00	12.00	21.00	28.00
Inventory	-6.7%	1.00	1.00	1.00	2.00	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net PPE	-2.6%	14.00	14.00	14.00	14.00	13.00	12.00	10.00	9.00	3.00	2.00	1.00	6.00	10.00	11.00	11.00	11.00	12.00	16.00	16.00	16.00	16.00
Goodwill	0%	4.00	4.00	4.00	3.00	4.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities	-3.6%	83.00	86.00	77.00	102	106	51.00	48.00	47.00	46.00	44.00	39.00	47.00	49.00	51.00	54.00	56.00	23.00	20.00	20.00	21.00	21.00
Current Liabilities	-5.4%	44.00	46.00	36.00	44.00	47.00	11.00	13.00	12.00	9.00	9.00	8.00	9.00	12.00	13.00	18.00	18.00	11.00	9.00	8.00	8.00	7.00
Long Term Debt	-	-	-	-	17.00	17.00	-	-	-	0.00	0.00	1.00	1.00	-	-	-	-	-	-	-	-	-
LT Debt, Current	-	-	-	-	-	-	-	-	-	1.00	0.00	0.00	-	-	-	-	-	-	-	-	-	-
LT Debt, Non Current	-	-	-	-	17.00	17.00	-	-	-	0.00	0.00	1.00	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	-100.0%	-	5.00	7.00	12.00	6.00	18.00	26.00	32.00	1.00	3.00	7.00	-	-	-	-	-	-	6.00	10.00	18.00	26.00
Retained Earnings	-4.6%	-324	-310	-307	-301	-292	-278	-270	-264	-258	-249	-242	-234	-226	-219	-214	-204	-196	-188	-185	-176	-168
Additional Paid-In Capital	2.1%	322	315	314	314	298	297	297	297	259	252	250	234	214	198	197	196	196	195	195	195	194
Shares Outstanding	13.3%	28.00	25.00	24.00	21.00	19.00	19.00	19.00	15.00	15.00	15.00	13.00	6.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	49.00	-	-	-	188	-	-	-	57.00	-	-	-	57.00	-	-	-	52.00	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3	2018Q2	2018Q1
Cashflow From Operations	61.7%	-4,250	-11,108	-9,430	-11,110	766	-8,741	-5,047	-2,388	-8,601	-9,192	-8,078	-6,352	-7,438	-8,455	-10,495	1,184	-2,110	-3,749	-8,359	-6,869	-9,648
Share Based Compensation	-19.7%	431	537	509	453	381	359	177	-341	80.00	476	141	419	272	-606	690	1,540	214	301	470	546	887
Cashflow From Investing	97.8%	-23.00	-1,065	-3,001	-1,872	-12,921	-4,027	-690	-1,876	-934	-36.00	252	-5.00	-337	-384	-5.00	-16.00	-17.00	-230	-465	-223	-140
Cashflow From Financing	-61.5%	4,095	10,633	-9,968	14,792	562	4.00	-105	37,405	6,789	2,035	14,901	20,030	15,848	545	261	25,000	10.00	-	13.00	-24.00	35,364

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NOVN Income Statement

2023-03-31

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total revenue	$ 3,166	$ 1,928
Operating expenses:
Cost of goods sold	1,285	206
Research and development	4,832	4,833
Selling, general and administrative	10,040	9,994
Amortization of intangible assets	477	121
Change in fair value of contingent consideration	365	0
Total operating expenses	16,999	15,154
Operating loss	(13,833)	(13,226)
Other income (expense), net:
Interest income	30	3
Interest expense	(277)	(132)
Other income (expense)	17	(25)
Total other income (expense), net	(230)	(154)
Net loss before income taxes	(14,063)	(13,380)
Provision for income tax expense	56	0
Net loss	(14,119)	(13,380)
Comprehensive loss	$ (14,119)	$ (13,380)
Net loss per share, basic (in USD per share)	$ (0.54)	$ (0.71)
Net loss per share, diluted (in USD per share)	$ (0.54)	$ (0.71)
Weighted-average number of shares outstanding, basic (in shares)	26,115,986	18,829,534
Weighted-average common shares outstanding, diluted (in shares)	26,115,986	18,829,534
Net product revenues
Revenue from contract with customer	$ 2,411	$ 718
License and collaboration revenues
Revenue from contract with customer	585	1,174
Government research contracts and grants revenue
Government research contracts and grants revenue	$ 170	$ 36

NOVN Balance Sheet

2023-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 12,541	$ 12,316
Restricted cash, current	646	1,047
Accounts receivable, net	13,836	22,002
Inventory, net	1,116	1,196
Prepaid expenses and other current assets	4,547	5,807
Total current assets	32,686	42,368
Restricted cash, net of current portion	581	583
Property and equipment, net	13,521	13,882
Intangible assets, net	26,998	27,475
Other assets	195	210
Right-of-use lease assets	1,756	1,756
Goodwill	4,056	4,056
Total assets	79,793	90,330
Current liabilities:
Accounts payable	14,321	13,689
Accrued expenses	18,238	18,624
Factoring arrangement payable	7,922	10,302
Deferred revenue, current portion	2,586	2,586
Research and development service obligation liability, current portion	378	555
Contingent consideration liability, current portion	0	451
Operating lease liabilities, current portion	465	191
Total current liabilities	43,910	46,398
Deferred revenue, net of current portion	7,433	8,079
Operating lease liabilities, net of current portion	3,387	3,739
Research and development service obligation liability, net of current portion	0	25
Research and development funding arrangement liability	25,000	25,000
Contingent consideration liability, net of current portion	2,353	2,037
Deferred tax liability	56	0
Other long-term liabilities	482	447
Total liabilities	82,621	85,725
Commitments and contingencies (Note 10)
Stockholders’ (deficit) equity
Common stock $0.0001 par value; 200,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 28,016,321 and 24,723,258 shares issued as of March 31, 2023 and December 31, 2022, respectively; 28,015,371 and 24,722,308 shares outstanding as of March 31, 2023 and December 31, 2022, respectively	3	2
Additional paid-in capital	321,723	315,038
Treasury stock at cost, 950 shares as of March 31, 2023 and December 31, 2022	(155)	(155)
Accumulated deficit	(324,399)	(310,280)
Total stockholders’ (deficit) equity	(2,828)	4,605
Total liabilities and stockholders’ (deficit) equity	$ 79,793	$ 90,330

About Novan Inc

WEBSITE	novan.com

Novan Inc Frequently Asked Questions

What is the ticker symbol for Novan Inc? What does NOVN stand for in stocks?

NOVN is the stock ticker symbol of Novan Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Novan Inc (NOVN)?

As of Tue Sep 26 2023, market cap of Novan Inc is 840.46 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NOVN stock?

You can check NOVN's fair value in chart for subscribers.

What is the fair value of NOVN stock?

You can check NOVN's fair value in chart for subscribers. The fair value of Novan Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Novan Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NOVN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Novan Inc a good stock to buy?

The fair value guage provides a quick view whether NOVN is over valued or under valued. Whether Novan Inc is cheap or expensive depends on the assumptions which impact Novan Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NOVN.

What is Novan Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Sep 26 2023, NOVN's PE ratio (Price to Earnings) is -0.03 and Price to Sales (PS) ratio is 0.03. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NOVN PE ratio will change depending on the future growth rate expectations of investors.